Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Niraj, Rathi"'
Autor:
Goran Stevanovic, Aleksandar Obradovic, Snezana Ristic, Dragan Petrovic, Branislava Milenkovic, Danilo Mitrovic, Svetlana Filipovic Vignjevic, Katarina Ilic, Vera Stoiljkovic, Lidija Lavadinovic, Mijomir Pelemis, Svetlana Petrovic, Ana Vidmanic, Olga Popovic, Natasa Eremic, Erin Sparrow, Guido Torelli, Muriel Socquet, Renée Holt, Yordanka Ilieva-Borisova, Yuxiao Tang, Francesco Berlanda Scorza, Jorge Flores, Niraj Rathi
Publikováno v:
Therapeutic Advances in Vaccines and Immunotherapy, Vol 8 (2020)
This study was a phase III, multicenter, double-blind, randomized, placebo-controlled trial to evaluate the safety and immunogenicity of a seasonal trivalent split, inactivated influenza vaccine (TIV) in healthy Serbian adults between the ages of 18
Externí odkaz:
https://doaj.org/article/1fb3d26d2cea44f3b3dcf12284b2c3bb
Autor:
Masuzyo Chirwa, C Chipeta, N Bhat, R M Velu, Gagandeep Kang, Niraj Rathi, N Katanekwa, Katayi Mwila-Kazimbaya, S Babji, Nsofwa Sukwa, Nicole Meyer, Monica M. McNeal, Yuxiao Tang, G. Gompana, Roma Chilengi, Jorge Flores, S Hazra
Publikováno v:
Vaccine
Background and Aims ROTAVAC® (frozen formulation stored at −20 °C) and ROTAVAC 5D® (liquid formulation stable at 2–8 °C) are rotavirus vaccines derived from the 116E human neonatal rotavirus strain, developed and licensed in India. This study
Autor:
Stevanovic, Goran, Obradovic, Aleksandar, Ristic, Snezana, Petrovic, Dragan, Milenkovic, Branislava, Mitrovic, Danilo, Vignjevic, Svetlana Filipovic, Ilic, Katarina, Stoiljkovic, Vera, Lavadinovic, Lidija, Mijomir Pelemis, Petrovic, Svetlana, Vidmanic, Ana, Popovic, Olga, Natasa Eremic, Sparrow, Erin, Torelli, Guido, Socquet, Muriel, Holt, Renée, Yordanka Ilieva-Borisova, Yuxiao Tang, Scorza, Francesco Berlanda, Flores, Jorge, Niraj Rathi
Supplemental material, Supplementary_tables for Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a double blind, phase III randomized clinical trial in healthy Serbian adults by Goran Stevanovic, Aleksandar Obrad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f3501c4c5562d6855387f1e3ff3591c
Autor:
P. Venugopal, Niraj Rathi, Jorge Flores, Prabal Niyogi, Anand Kawade, Prasad S. Kulkarni, J. Venkateswara Rao, Sajjad Desai, Kalpana Antony, Bhagwat Gunale, Yuxiao Tang, Sanjay Lalwani, Renuka Munshi, Alpana Kondekar, Ashish Bavdekar, Mukesh C Agarwal, H S Rajani, Ritabrata Kundu, D. Narayanappa, Gagandeep Kang, Radha Ghildiyal, Sonali Palkar, Sanjay Juvekar, Padmasani Venkatramanan, Kheya Ghosh Uttam, N. K. Ganguly, Sudhir Babji, Smilu Mohanlal, Nithya J Gogtay, Anand Prakash Dubey, Dipti Kumbhar, Parvan Shetty, Abhijeet Dharmadhikari
Publikováno v:
Vaccine. 37(23)
Autor:
Sajjad, Desai, Niraj, Rathi, Anand, Kawade, Padmasani, Venkatramanan, Ritabrata, Kundu, Sanjay K, Lalwani, A P, Dubey, J, Venkateswara Rao, D, Narayanappa, Radha, Ghildiyal, Nithya J, Gogtay, P, Venugopal, Sonali, Palkar, Renuka, Munshi, Ashish, Bavdekar, Sanjay, Juvekar, Nupur, Ganguly, Prabal, Niyogi, Kheya Ghosh, Uttam, Alpana, Kondekar, Dipti, Kumbhar, Smilu, Mohanlal, Mukesh C, Agarwal, Parvan, Shetty, Kalpana, Antony, Bhagwat, Gunale, Abhijeet, Dharmadhikari, Jagdish, Deshpande, Uma, Nalavade, Deepa, Sharma, Anurag, Bansal, Yuxiao, Tang, Jorge, Flores, Prasad S, Kulkarni
Publikováno v:
Vaccine. 36(37)
A newly developed bovine-human reassortant pentavalent vaccine (BRV-PV, ROTASIIL®) was tested for its potential effect on the immunogenicity of concomitantly administered EPI vaccines in infants in a randomized controlled study in India.In this Phas
Autor:
Niraj Rathi, Zhaojun Mo, Xue-Yan Liao, Yi Nong, Htay Htay Han, Yanping Li, Junhui Tao, Naveen Karkada, Guoai Si, Lao-Hong Wang, Botao Fu, Haiwen Tang, Teng Huang, Ivy Luan, Rong-cheng Li
Publikováno v:
Human Vaccines & Immunotherapeutics
This study evaluated the immunogenicity of the human rotavirus (RV) vaccine (RIX4414) when co-administered with routine childhood vaccines in Chinese infants (NCT01171963). Healthy infants aged 6–16 weeks received 2 doses of either RIX4414 or place
Autor:
Sherine Kuriyakose, Niraj Rathi, Htay Htay Han, Karel Hoppenbrouwers, Pierre Van Damme, Heidi Theeten, Corinne Vandermeulen, Etienne Sokal
Publikováno v:
Vaccine
BACKGROUND: Regular booster vaccination might be necessary throughout life to protect against pertussis infection. Nevertheless the duration of protection after booster vaccination remains unclear. In this study, antibody persistence up to 10 years a
Autor:
Yanping Li, Xue-Yan Liao, Htay Htay Han, Junhui Tao, Ivy Luan, Haiwen Tang, Rong-cheng Li, Teng Huang, Naveen Karkada, Yi Nong, Dong Luo, Guoai Si, Zhaojun Mo, Botao Fu, Niraj Rathi
Publikováno v:
Human Vaccines & Immunotherapeutics
Rotaviruses (RV) are a major cause of severe gastroenteritis (GE) in children aged 10%. The number of unsolicited symptoms and SAEs reported was similar between both groups. Thirteen deaths (RIX4414 = 6; placebo = 7) occurred during the study. All SA
Publikováno v:
Vaccine. 33(22)
Background Pertussis in adults and adolescents could be reduced by replacing traditional tetanus and diphtheria (Td) boosters with reduced-antigen-content diphtheria–tetanus–acellular pertussis (dTpa) vaccines. This study evaluated the administra
Autor:
Rong-cheng Li, Teng Huang, Yanping Li, Dong Luo, Junhui Tao, Botao Fu, Guoai Si, Yi Nong, Zhaojun Mo, XueYan Liao, Ivy Luan, Haiwen Tang, Niraj Rathi, Naveen Karkada, Htay Htay Han
Publikováno v:
Human Vaccines & Immunotherapeutics; Jan2014, Vol. 10 Issue 1, p1-8, 8p